Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: International Conference on Prevention & Infection Control (ICPIC 2011)

Open Access Poster presentation

An active dressing prevents formation of Staphylococcus aureus biofilm on a mucosal surface

P Parks1*, M Anderson2 and M Peterson2

  • * Corresponding author: P Parks

Author Affiliations

1 Exp Clin Pharmacol, 3M/UnivMinn, Minneapolis, USA

2 ExpClinPharmacol, Univ Minnesota, Minneapolis, USA

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 6):P62  doi:10.1186/1753-6561-5-S6-P62

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/5/S6/P62


Published:29 June 2011

© 2011 Parks et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction / objectives

An antiseptic containing dressing is used to minimize the risk of nosocomial infections including Staphylococcus aureus, which can invade via skin or mucosal surfaces. This study developed a mucosal model of S. aureus biofilm formation and determined the effect of the active dressing (Tegaderm CHG) on biofilm formation and mucosal integrity.

Methods

Explants of normal porcine vaginal mucosa (full-thickness) were infected with biofilm-producing methicillin-resistant S. aureus (MRSA) (3.2x10^5 CFU) for 2h – 48h. Following infection (2h), explants were treated with the active dressing (Tegaderm CHG) for 22-46h or left untreated (controls). Formation of MRSA biofilm was evaluated by scanning electron microscopy. Also, bacteria were enumerated from infected explants, which were washed 3x in PBS by vortex mixing and compared to unwashed explants, to determine the effects of the active dressing (Tegaderm CHG) on MRSA growth.

Results

MRSA exhibited typical growth on porcine vaginal mucosa. MRSA recovered from infected mucosa at 24h were mainly adherent [washed (adherent): 6.71±0.07; vs. total (planktonic + adherent) 8.27±0.06 log10 CFU/explant]. Biofilm was evident on MRSA-infected vaginal mucosa at 24 h via SEM, and MRSA disrupted the integrity of the mucosal surface. Active dressing (Tegaderm CHG) exposures for 24h reduced the number of MRSA to 3.44±1.00 vs. untreated controls 7.90±0.00 log10 CFU/explant. At 48h, no bacteria were detected in the active dressing (Tegaderm CHG) treated group compared to untreated controls 7.96±0.15 log10 CFU/explant.

Conclusion

MRSA biofilms can form on normal healthy mucosal tissue. An antiseptic containing active dressing (Tegaderm CHG) prevented MRSA biofilm formation.

Disclosure of interest

None declared.